PBMs Sue to Block FTC Administrative Action Alleging Inflated Insulin Prices
- November 22, 2024
The nation’s largest pharmacy benefit managers (PBMs) sued November 19 the Federal Tade Commission (FTC) arguing the agency’s administrative action against them over insulin prices is unconstitutional.
ARTICLE TAGS
You must be logged in to access this content.